New Global Push to Fast-Track Vaccine for Rare Ebola Strain

A new global health initiative is aiming to speed up vaccine development for a rare strain of Ebola. The project, led by Gavi and CEPI, targets the Bundibugyo virus—a less common but dangerous pathogen. Its goal is to fill a long-standing gap in epidemic preparedness for unpredictable diseases. Historically, vaccine development for rare Ebola strains like Bundibugyo has stalled. Manufacturers often hesitate due to uncertain demand, leaving critical gaps in global health defences. This initiative plans to change that by creating a trial-ready vaccine in just months.

Unlike past approaches, which waited for outbreaks before acting, the project will work proactively. Gavi and CEPI are driving the effort to ensure faster responses when new threats emerge.

The initiative seeks to deliver a vaccine candidate for Bundibugyo Ebola within a short timeframe. By addressing the lack of investment in rare pathogens, it aims to strengthen global readiness. A successful outcome would provide a model for tackling other unpredictable disease risks.